Hypertrophic Cardiomyopathy Clinical Trials in Beijing, Beijing Municipality
8 recruitingBeijing, Beijing Municipality, China
Showing 1–8 of 8 trials
Recruiting
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Hypertrophic Cardiomyopathy
Bristol-Myers Squibb500 enrolled15 locationsNCT07361289
Recruiting
Phase 1Phase 2
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
TumorCardiovascular DiseasesPulmonary Fibrosis+3 more
Peking Union Medical College Hospital30 enrolled1 locationNCT07464132
Recruiting
The Application of T1 Mapping in Real-World
Hypertrophic Cardiomyopathy (HCM)MyocarditisMyocardial Infarction (MI)+2 more
Chinese Academy of Medical Sciences, Fuwai Hospital2,000 enrolled1 locationNCT07354646
Recruiting
Not Applicable
REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy, Obstructive
SuZhou Sinus Medical Technologies Co.,Ltd124 enrolled2 locationsNCT07006493
Recruiting
Phase 2
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd.300 enrolled1 locationNCT07021963
Recruiting
Phase 3
A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
Obstructive Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd.216 enrolled1 locationNCT07021976
Recruiting
Phase 2
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
Non-obstructive Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd.84 enrolled1 locationNCT06816251
Recruiting
Phase 4
Use of SGLT2i in noHCM With HFpEF
Hypertrophic CardiomyopathyHeart Failure With Preserved Ejection Fraction
China National Center for Cardiovascular Diseases94 enrolled1 locationNCT06401343